Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par pays : United Kingdom
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)
The objective of this trial is to evaluate the efficacy and safety of two different treatment regimens with BI 201335, both in combination with PegIFN/RBV) as compared to standard of care ...
Pays
Austria
,
Belgium
,
France
,
Germany
,
Japan
,
Portugal
,
Romania
,
Russian Federation
,
Spain
,
Switzerland
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
North Bristol NHS Trust (UK)
MAJ Il y a 4 ans
Prospective randomised controlled study comparing an artificial cervical joint with anterior cervical fusion after a single level discetomy for spondylitic radiculopathy
Not provided at time of registration
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
This study will be performed to determine the long-term efficacy of 19.000 BU Oralgen grass pollen administered daily in patients with grass pollen related allergic rhinoconjunctivitis.
Pays
Belgium
,
France
,
Germany
,
Netherlands
,
Poland
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Ian Brook, Prof
MAJ Il y a 4 ans
Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery
The present study is aimed at demonstrating the therapeutic equivalence of diclofenac HPBCD 75mg/1ml s.c. with the marketed reference product, Voltarol® 75mg/3ml i.m. in the treatment of a...
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma
Acromegaly is a chronic disease caused by excessive secretion of growth hormone (GH) and mainly due to benign tumour localized in the pituitary gland. The disease develops insidiously, ca...
Pays
Belgium
,
Czech Republic
,
Finland
,
France
,
Germany
,
Italy
,
Netherlands
,
Turkey
,
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
European Commission (Contract number: QLG5-CT-2002-01938)
MAJ Il y a 4 ans
Towards more effective European Community care for patients with severe psychosis
Not provided at time of registration
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
nct
MAJ Il y a 4 ans
Safety and Efficacy of Seroquel in First Episode Schizophrenia
To compare the safety, tolerability and efficacy of Seroquel and risperidone in first episode schizophrenia
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Department of Health
MAJ Il y a 4 ans
Randomised double blind placebo controlled trial of the efficacy of gabapentin in improving analgesia in patients undergoing hysterectomy receiving patients controlled analgesia
Not provided at time of registration
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Department of Health (UK)
MAJ Il y a 4 ans
Haloperidol as an antiemetic following abdominal hysterectomy - a comparison with Zofran®
Not provided at time of registration
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
nct
MAJ Il y a 4 ans
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
Objectives: - To assess the safety of three priming immunisations by nasal route followed by two booster immunisations by intramuscular route - To assess immunogenicity ...
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
11
12
13
14
15
16
17
18
19
20
Suivant